Humacyte Stock (NASDAQ: HUMA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 18.76K / 2.62M |
Day Range | - - - |
52 Wk Range | 1.96 - 9.97 |
Market Cap | $614.48M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 5.76% |
Days to Cover | 2.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Humacyte (NASDAQ:HUMA) through any online brokerage.
Other companies in Humacyte’s space includes: Immunome (NASDAQ:IMNM), Celcuity (NASDAQ:CELC), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL) and Sage Therapeutics (NASDAQ:SAGE).
There is no analysis for Humacyte.
Humacyte has a consensus price target of $9.75.
The stock price for Humacyte (NASDAQ: HUMA) is $5.16 last updated Today at July 3, 2024 at 9:16 AM EDT.
There are no upcoming dividends for Humacyte.
Humacyte’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Humacyte.
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.